ArticleSpringerPlus2015

Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.

Jennifer Eremin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.